Welcome to our dedicated page for Alpha Cognition SEC filings (Ticker: ACOG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Alpha Cognition Inc. (NASDAQ: ACOG) SEC filings page on Stock Titan provides centralized access to the company’s U.S. regulatory disclosures. Alpha Cognition is an emerging growth, commercial-stage biopharmaceutical company focused on Alzheimer’s disease and other neurodegenerative conditions, and its filings offer detailed insight into how it finances, governs, and reports on its ZUNVEYL and ALPHA-1062 programs.
Through this page, users can review Current Reports on Form 8-K that document material events such as public offerings of common shares and pre-funded warrants, at-the-market offering agreements, changes in the independent registered public accounting firm, and adoption of equity incentive plans. For example, recent 8-Ks describe an underwriting agreement for a public offering intended to support ZUNVEYL commercialization, an ATM agreement with a sales agent for up to a specified aggregate amount of common shares, and the transition from a Canada-based auditor to a U.S.-licensed firm following relocation of principal executive offices to Texas.
Investors can also use this page to monitor corporate governance and compensation matters, including shareholder votes on the number of directors, director elections, ratification of auditors, and approval of stock incentive plans, as reported in meeting-related filings. These documents help clarify how Alpha Cognition structures its board, aligns management incentives, and complies with exchange and securities regulations.
Stock Titan enhances these filings with AI-powered summaries that highlight key terms, financial implications, and governance changes, reducing the time needed to interpret lengthy documents. Real-time integration with the SEC’s EDGAR system means new ACOG filings appear promptly, while dedicated sections for material agreements and capital markets activity make it easier to follow offerings, ATM usage, and other financing tools. For users interested in deeper due diligence on Alpha Cognition’s Alzheimer’s-focused business, this page serves as a structured entry point into the company’s official regulatory record.